Primary Navigation for the CDC Website
CDC en Español

Yellow Fever Links and References

Yellow Fever Frequently Asked Questions

Yellow Fever Information for Travelers (from CDC’s travelers’ health website):

Yellow Fever Information for Health Care Providers

Yellow Fever Information from International Health Institutions:

Yellow Fever in Morbidity and Mortality Weekly Reports:

Yellow Fever in Select Publications:
Hayes EB. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg. 2007 Oct;101(10):967-71.

McMahon AW, Eidex RB, Marfin AA, et. al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases, Vaccine. 2007:25:1727-34.

Monath TP. Yellow fever vaccine. In: S. Plotkin, W. Orenstein and P.A. Offit, Editors, Vaccines (4th ed.), Saunders, Philadelphia. 2004. 1095–1176.

Chan RC, Penney DJ, Little D, et al. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001;358:121-2.

Martin M, Tsai TF, Cropp B, Chang GJ, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 2001;358:98-104.

Vasconcelos PF, Luna EJ, Galler R, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001;358:91-7.

Centers for Disease Control and Prevention. Notice to readers: Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996–2001.
MMWR 2001;50:343-5.

Vellozzi C, Mitchell T, Miller E, Casey CG, Eidex RB, Hayes EB.  Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004.Am J Trop Med Hyg 2006;75(2):333-6.

Huhn GD, Brown J,Perea W,Berthe A,Otero H,LiBeau G, Maksha N,Sankoh M, Montgomery S, Marfin A, Admassu M.  Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004. Vaccine 2006; 24(6):730-7.

Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR.  West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.  Vector Borne Zoonotic Dis 2005;5(2):137-45.

Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications.  Infect Dis Clin North Am. 2005 Mar;19(1):151-68, ix. Review.

Chang GJ, Kuno G, Purdy DE, Davis BS.  Recent advancement in flavivirus vaccine development. Expert Rev Vaccines. 2004 Apr;3(2):199-220. Review.

Heymann DL. Control of Communicable Diseases Manual, 18th edition. Washington, DC: American Public Health Association, 2004.

Gubler DJ.  The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002;33(4):330-42. Review.

Gubler DJ. Yellow fever. IN: Feigin RD and Cherry JD (eds.) Textbook of Pediatric Infectious Diseases, 4th ed., Philadelphia, PA: W.B. Saunders, 1998:1981-84.

Page last modified: June 11, 2007
Content Source:
Division of Vector Borne Infectious Diseases
National Center for Zoonotic, Vector-Borne, and Enteric Diseases